… (RAAS), ACE inhibitors and ARB clinical … clinical trial data. It is envisioned that an updated
and detailed understanding of ACE inhibitors and ARBs will facilitate their successful use in …

… angiotensin-converting enzyme (ACE) inhibitors. The purpose of this paper is to review clinical
studies assessing the effect of long-term, oral ACE inhibition on endothelial dysfunction in …

… The impact of enzyme inhibitors … enzyme inhibitors are currently marketed and double than
those are under development. Such inhibitors exhibit their specific action in enzyme inhibition …

… enzyme molecules as well. Within the collection of enzyme inhibitors that are presently in
clinical use as drugs, one finds representatives of all of these inhibition modalities, as well as …

SUMMARY An orally Retire inhibitor of the angtotensin conrerting enzyme, SQ 14,225 or
captopril, was administered to 14 normal rolnnteers to evaluate its efficacy in inhibiting the …

… Angiotensin receptor blockers showed the highest reduction in systolic and diastolic blood
pressure compared with angiotensin-converting enzyme inhibitors and direct renin inhibitors. …

… The intent of this review is to integrate relevant human basic science and outcome data in
order to promote a sophisticated yet practical approach to clinical use of ACE inhibitors. In …

… The angiotensin converting enzyme inhibitors are an important therapeutic advance in the
… Captopril was the first angiotensin converting enzyme inhibitor approved for use in patients …

… normal level, whereas residual enzyme activity can be detected … enzyme inhibitors can
effectively increase mutant enzyme … sub-inhibitory concentrations, and we proposed that enzyme …

… the description of enzyme inhibitors which have found use in clinical practice and also the …
a catalogue of enzymes, diseases, enzyme inhibitors, and their attendant clinical benefits. This …